Besides, the upregulation of IL-6 in CRC-derived mesenchymal stem cells (CC-MSCs) results in enhanced metastasis and survival of patients with CRC; this is attributed to the activation of PI3K/AKT via IL-6/JAK2/STAT3 signaling [180]. The gene discussed is AKT1; the disease is colorectal carcinoma.